Back
Regenxbio Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
33
RGNX
Regenxbio
Last Price:
11.14
Seasonality Move:
-5.66%
Buy
60
EYPT
EyePoint Pharmaceuticals
Last Price:
10.48
Seasonality Move:
27.28%
Sell
33
Regenxbio (RGNX)
is a Sell
Is Regenxbio a Buy, Sell or Hold?
- The current Regenxbio [RGNX] share price is $10.68. The Score for RGNX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RGNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $10.75. The Score for EYPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $10.75
The current trend is moderately bearish and EYPT is experiencing slight selling pressure.
RGNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 55.25 | Buy |
| Chaikin Money Flow: | 455935 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.99 - 10.71) | Buy |
| Bollinger Bands (100): | (10.02 - 12.88) | Sell |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 49.8 | Sell |
| Chaikin Money Flow: | -275652 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.64 - 11.94) | Sell |
| Bollinger Bands (100): | (8.06 - 10.44) | Buy |
RGNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.28 | Buy |
| 20-day SMA: | 9.87 | Buy |
| 50-day SMA: | 10.55 | Buy |
| 200-day SMA: | 14.35 | Sell |
| 8-day EMA: | 10.41 | Buy |
| 20-day EMA: | 10.09 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 13.43 | Sell |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.56 | Sell |
| 20-day SMA: | 11.21 | Sell |
| 50-day SMA: | 9.61 | Buy |
| 200-day SMA: | 14.21 | Sell |
| 8-day EMA: | 11.37 | Sell |
| 20-day EMA: | 11.01 | Sell |
| 50-day EMA: | 10.18 | Buy |
| 200-day EMA: | 11.63 | Sell |
Regenxbio Earnings Growth & RGNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $4.23 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.43 per share.
Regenxbio Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||